A flowering Tibetan shrub that tricks cells into
thinking they are starving could become a weapon against multiple
sclerosis and even old age.
The roots of the blue evergreen hydrangea (Dichroa febrifuga) have been used for centuries in traditional Chinese medicine to treat malaria. Now Tracy Keller
and colleagues at the Harvard School of Dental Medicine in Boston have
found that halofuginone – a chemical based on the roots' active
ingredient – blocks immune reactions that can cause disease.
Cells
stop the synthesis of non-vital proteins when amino acids are in short
supply. Keller's team discovered that halofuginone mimics such a
shortage by blocking an enzyme that feeds one amino acid to the
protein-making machinery.
Keller
found that the drug triggers a chemical cascade that responds to amino
acid scarcity, called AAR. This inhibits the growth of malaria
parasites, stops blood cells from making proteins that cause
inflammation, and stops the development of specific white blood cells
that trigger conditions such as inflammatory bowel disease and multiple
sclerosis.
This
could make the drug effective against autoimmune disease. But as
halofuginone mimics nutrient deprivation, there is another possible
use. Animals that receive only just adequate nutrition are known to live longer,
partly because diseases which involve inflammation are prevented. That,
says Keller, means halofuginone might possibly work as an anti-ageing
drug.
Journal reference: Nature Chemical Biology, DOI: 10.1038/nchembio.790
http://www.newscientist.com/
No comments:
Post a Comment